Asia-Pacific (APAC) Embolization Particle Procedures Count by Segments and Forecast to 2030
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Asia-Pacific (APAC) Embolization Particle Procedures Market Report Overview
The total number of Embolization Particle Procedures performed in APAC was 75,044 in 2022. In procedures using embolization particles, a small catheter is placed inside a blood vessel to reach the area that is bleeding, and the catheter is navigated under image guidance to the farthest point with other different embolic materials that help block the bleeding vessels. APAC Embolization Particle Procedures market research report is a comprehensive databook, covering key procedures data on the Asia-Pacific Embolization Particle Procedures.
APAC Embolization Particle Procedures Market Segmentation
The key segments in the APAC Embolization Particle Procedures market are Embolization Particle Procedures to treat Benign prostatic hyperplasia, Embolization Particle Procedures to treat Uterine Fibroids, Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Embolization Particle Procedures to treat Renal Cell Carcinoma, Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, and Embolization Particle Procedures to treat Arteriovenous Malformations. Embolization Particle Procedures to treat Benign prostatic Hyperplasia dominated the APAC Embolization Particle Procedures market in terms of volume.
Embolization Particle Procedures to treat Benign prostatic hyperplasia: Embolization Particle Procedures to treat benign prostatic hyperplasia (BPH) includes sub-segments such as procedures using microspheres and procedures using polyvinyl alcohol (PVA) particles. Lower urinary tract infections caused by BPH is treated by prostatic artery embolization (PAE), an embolization procedure. A tiny hole is made in the groin to execute prostatic artery embolization. Through the artery, a catheter is inserted and pointed at the prostate. Once the catheter is in the prostate’s blood vessel, a little amount of material is injected to limit blood flow by plugging the artery.
Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease includes sub-segments such as Procedures using Drug-Eluting Beads, Procedures using Microspheres, Procedures using Polyvinyl Alcohol (PVA) Particles and Procedures using Radioembolization Particles. One of the main causes of death from colorectal cancer is liver metastases. By Embolization procedure, embolization substances are directly injected through a catheter into the colon to block or reduce the blood flow to the tumor.
APAC Embolization Particle Procedures Market by Segments, 2022(%)
For more insights on the segments of APAC Embolization Particle Procedures market, download a free report sample
APAC Embolization Particle Procedures Market by Country
The key countries in the APAC Embolization Particle Procedures market are Australia, China, India, Japan and South Korea. In the year 2022, China dominated the APAC Embolization Particle Procedures market, followed by India and Japan respectively.
APAC Embolization Particle Procedures Market by Country, 2022(%)
For more country insights on APAC Embolization Particle Procedures market, download a free report sample
APAC Embolization Particle Procedures Market Outlook
Market Size (2022) | 75,044 |
Historical period | 2015-2022 |
Forecast period | 2023-2030 |
Key Segments | Embolization Particle Procedures to treat Benign prostatic hyperplasia, Embolization Particle Procedures to treat Uterine Fibroids, Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Embolization Particle Procedures to treat Renal Cell Carcinoma, Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, and Embolization Particle Procedures to treat Arteriovenous Malformations |
Key Countries | Australia, China, India, Japan and South Korea |
Segments Covered in the Report
Asia-Pacific Embolization Particle Procedures Market Segments Outlook (Number of Procedures, 2022)
- Embolization Particle Procedures to treat Arteriovenous Malformation
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Benign prostatic Hyperplasia
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Procedures using Radioembolization
- Embolization Particle Procedures to treat Hepatocellular Carcinoma
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Procedures using Radioembolization Particles
- Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Procedures using Radioembolization Particles
- Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Procedures using Radioembolization Particles
- Embolization Particle Procedures to treat other tumors with Metastatic Liver Disease
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Procedures using Radioembolization Particles
- Embolization Particle Procedures to treat Renal Cell Carcinoma
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Procedures using Radioembolization Particles
- Embolization Particle Procedures to treat Uterine Fibroids
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles.
Asia-Pacific Embolization Particle Procedures Market Country Outlook (Number of Procedures, 2022)
- Australia
- China
- India
- Japan
- South Korea
Scope
Asia-Pacific Embolization Particle Procedures is segmented as follows –
• Embolization Particle Procedures to treat Arteriovenous Malformations
• Embolization Particle Procedures to treat Benign prostatic hyperplasia
• Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease
• Embolization Particle Procedures to treat Hepatocellular Carcinoma
• Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma
• Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease
• Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease
• Embolization Particle Procedures to treat Renal Cell Carcinoma
• Embolization Particle Procedures to treat Uterine Fibroids
Reasons to Buy
The Asia-Pacific Embolization Particle Procedures report helps you to develop –
- Business strategies by identifying the key segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Develop investment strategies by identifying the key segments expected to register strong growth in the near future.
Table of Contents
Table
Figures
Frequently asked questions
-
What was the Asia-Pacific Embolization Particle Procedures market size in 2022?
The total number of Embolization Particle Procedures performed in APAC was 75,044 in 2022.
-
Which segment dominated the Asia-Pacific Embolization Particle Procedures market in 2022?
Embolization Particle Procedures to treat Benign prostatic hyperplasia dominated the APAC Embolization Particle Procedures market in terms of volume in 2022.
-
Which country dominated the Asia-Pacific Embolization Particle Procedures market in 2022?
China dominated the APAC Embolization Particle Procedures market in 2022.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.